Experienced in Diskitis

Fehmi Tabak

Istanbul, TR 
Experienced in Diskitis
Istanbul, TR 
OverviewLocationsClinical Research

Overview

Fehmi Tabak practices in Istanbul, Turkey. Tabak is rated as an Experienced expert by MediFind in the treatment of Diskitis. Their top areas of expertise are Hepatitis B, Hepatitis, Hepatitis D, and Febrile Neutropenia.

Their clinical research consists of co-authoring 136 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Diskitis.

Locations

Istanbul, Turkey
Other Locations
Ankara, Turkey
Cerrahpasa, Turkey
Gaziosmanpasa, Turkey
Fatih, 34098, Turkey
Beylerbeyi, 81210, Turkey

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase 3, Randomized, Open-Label, Parallel Arm Study to Evaluate the Efficacy and Safety of 180 mcg Peginterferon Lambda-1a (Lambda) Subcutaneous Injection for 48 Weeks in Patients With Chronic Hepatitis Delta Virus (HDV) Infection (LIMT-2)
Phase 3, Randomized, Open-Label, Parallel Arm Study to Evaluate the Efficacy and Safety of 180 mcg Peginterferon Lambda-1a (Lambda) Subcutaneous Injection for 48 Weeks in Patients With Chronic Hepatitis Delta Virus (HDV) Infection (LIMT-2)
Enrollment Status: Unknown
Publish Date: August 25, 2023
Intervention Type: Drug
Study Drug: Peginterferon Lambda-1a
Study Phase: Phase 3
Evaluation of Efficacy and Safety of Direct Acting Agents in Hepatitis C Patients
Evaluation of Efficacy and Safety of Direct Acting Agents in Hepatitis C Patients
Enrollment Status: Completed
Publish Date: October 01, 2019
View 1 Less Clinical Trial

136 Total Publications

The impact of cART on hepatic steatosis and fibrosis in treatment-naïve PLwHIV: A prospective cohort study.
The impact of cART on hepatic steatosis and fibrosis in treatment-naïve PLwHIV: A prospective cohort study.
Journal: International journal of STD & AIDS
Published: September 23, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Tabak's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 18 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile